Your browser doesn't support javascript.
loading
Novel flavonolignan hybrid antioxidants: From enzymatic preparation to molecular rationalization.
Vavríková, Eva; Kren, Vladimír; Jezova-Kalachova, Lubica; Biler, Michal; Chantemargue, Benjamin; Pyszková, Michaela; Riva, Sergio; Kuzma, Marek; Valentová, Katerina; Ulrichová, Jitka; Vrba, Jirí; Trouillas, Patrick; Vacek, Jan.
Afiliação
  • Vavríková E; Laboratory of Biotransformation, Institute of Microbiology, Czech Academy of Sciences, Vídenská 1083, Prague, 142 20, Czech Republic.
  • Kren V; Laboratory of Biotransformation, Institute of Microbiology, Czech Academy of Sciences, Vídenská 1083, Prague, 142 20, Czech Republic.
  • Jezova-Kalachova L; Laboratory of Biotransformation, Institute of Microbiology, Czech Academy of Sciences, Vídenská 1083, Prague, 142 20, Czech Republic.
  • Biler M; INSERM U850, Univ. Limoges, School of Pharmacy, 2 rue du Docteur Marcland, 87025 Limoges, France; Department of Biophysics, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University, Slechtitelu 11, 783 71, Olomouc, Czech Republic.
  • Chantemargue B; INSERM U850, Univ. Limoges, School of Pharmacy, 2 rue du Docteur Marcland, 87025 Limoges, France; Regional Centre of Advanced Technologies and Materials, Department of Physical Chemistry, Faculty of Science, Palacký University, tr. 17. listopadu 12, 771 46 Olomouc, Czech Republic.
  • Pyszková M; Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, Hnevotínská 3, Olomouc, 775 15, Czech Republic.
  • Riva S; Istituto di Chimica del Riconoscimento Molecolare, C.N.R., Via Mario Bianco 9, Milano, I-20131, Italy.
  • Kuzma M; Laboratory of Biotransformation, Institute of Microbiology, Czech Academy of Sciences, Vídenská 1083, Prague, 142 20, Czech Republic.
  • Valentová K; Laboratory of Biotransformation, Institute of Microbiology, Czech Academy of Sciences, Vídenská 1083, Prague, 142 20, Czech Republic.
  • Ulrichová J; Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, Hnevotínská 3, Olomouc, 775 15, Czech Republic.
  • Vrba J; Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, Hnevotínská 3, Olomouc, 775 15, Czech Republic.
  • Trouillas P; INSERM U850, Univ. Limoges, School of Pharmacy, 2 rue du Docteur Marcland, 87025 Limoges, France; Regional Centre of Advanced Technologies and Materials, Department of Physical Chemistry, Faculty of Science, Palacký University, tr. 17. listopadu 12, 771 46 Olomouc, Czech Republic.
  • Vacek J; Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, Hnevotínská 3, Olomouc, 775 15, Czech Republic. Electronic address: jan.vacek@upol.cz.
Eur J Med Chem ; 127: 263-274, 2017 Feb 15.
Article em En | MEDLINE | ID: mdl-28068598
ABSTRACT
A series of antioxidants was designed and synthesized based on conjugation of the hepatoprotective flavonolignan silybin with l-ascorbic acid, trolox alcohol or tyrosol via a C12 aliphatic linker. These hybrid molecules were prepared from 12-vinyl dodecanedioate-23-O-silybin using the enzymatic regioselective acylation procedure with Novozym 435 (lipase B) or with lipase PS. Voltammetric analyses showed that the silybin-ascorbic acid conjugate exhibited excellent electron donating ability, in comparison to the other conjugates. Free radical scavenging, antioxidant activities and cytoprotective action were evaluated. The silybin-ascorbic acid hybrid exhibited the best activities (IC50 = 30.2 µM) in terms of lipid peroxidation inhibition. The promising protective action of the conjugate against lipid peroxidation can be attributed to modulated electron transfer abilities of both the silybin and ascorbate moieties, but also to the hydrophobic C12 linker facilitating membrane insertion. This was supported experimentally and theoretically by density functional theory (DFT) and molecular dynamics (MD) calculations. The results presented here can be used in the further development of novel multipotent antioxidants and cytoprotective agents, in particular for substances acting at an aqueous/lipid interface.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Flavonolignanos / Lipase / Antioxidantes Limite: Humans Idioma: En Revista: Eur J Med Chem Ano de publicação: 2017 Tipo de documento: Article País de afiliação: República Tcheca

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Flavonolignanos / Lipase / Antioxidantes Limite: Humans Idioma: En Revista: Eur J Med Chem Ano de publicação: 2017 Tipo de documento: Article País de afiliação: República Tcheca